NutriDex

The Supplement Research Compendium
🌻

Vitamin E (Tocopherol)

Alpha-tocopherol

Real antioxidant, but the scar-fading reputation is largely a myth

Mixed evidence 🍊Vitamin✨Joint & Skin

✚ Updated · How we grade evidence

Evidence tier
Mixed
Research weight
Citations
20 verified / 20
Classification
Vitamin
❝
What the evidence says. Conflicting results across studies; benefit uncertain.

What is Vitamin E (Tocopherol)?

Vitamin E (Tocopherol) (Alpha-tocopherol) is a vitamin used for lipid-soluble antioxidant in skin. NutriDex grades the human evidence as Mixed. Vitamin E (alpha-tocopherol) is a genuine lipid-soluble antioxidant that neutralizes reactive oxygen species in skin lipids — the basis of most cosmetic claims. However, its most popular use, topical vitamin E for scars or wound healing, is not supported: the landmark Baumann 1999 RCT found no cosmetic benefit and caused contact dermatitis in about a third of patients. Oral supplementation for skin appearance has weak, indirect evidence. The strongest signal is photoprotection when topical vitamin E is combined with vitamin C, though much of that work is in animal or small models. High-dose oral vitamin E carries its own risks, including bleeding and an association with higher all-cause mortality at ≥400 IU/day.

Purported Benefits

✓Lipid-soluble antioxidant in skin
✓May aid topical photoprotection with vitamin C
✓Possible barrier-lipid support (thin proof)
✓Popular for scars — but not supported

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Topical vitamin E for scars/wound cosmesisLandmark split-scar RCT found no cosmetic benefit and 33% contact dermatitis. Moderate — no effect · negligible 1
Topical photoprotection with vitamin CCombination C+E gave ~4-fold UV protection, but evidence is preclinical/experimental. Preliminary ↑ benefit · moderate 1
NAFLD/NASH liver histology & enzymesMultiple RCTs (PIVENS, Wang 2025) and meta-analyses improve histology and ALT/AST. Strong ↑ benefit · moderate 4
All-cause mortality at high doseMeta-analysis of 19 trials links >=400 IU/day to increased all-cause mortality. Moderate ⚠ risk · small 1
Prostate cancer riskSELECT RCT found 400 IU/day significantly increased prostate cancer risk. Moderate ⚠ risk · small 1
Hemorrhagic stroke / bleeding riskMeta-analyses show ~22% higher hemorrhagic stroke; EFSA cites bleeding as critical effect. Moderate ⚠ risk · small 2
Cardiovascular/cancer primary preventionUSPSTF and umbrella review find no net benefit of supplementation for prevention. Strong — no effect · negligible 2

Dosing & Compounds

Typical Dose
RDA ~15 mg/day (22.4 IU); doses ≥400 IU/day raise safety concerns.
Active Compounds
Alpha-tocopherolMixed tocopherols/tocotrienols

Safety & Cautions

Topical vitamin E commonly causes contact dermatitis (~1 in 3 in the Baumann scar trial). Oral vitamin E is safe at RDA levels (~15 mg/day), but high doses can increase bleeding risk (especially with anticoagulants or before surgery) and interfere with vitamin K; a 2005 meta-analysis linked ≥400 IU/day to higher all-cause mortality, so routine high-dose use for skin is not advisable. Educational only — always check with your doctor or pharmacist before combining Vitamin E (Tocopherol) with any medicine.

Vitamin E (Tocopherol) drug interactions

Known or theoretical interactions between Vitamin E (Tocopherol) and common medications — educational, not exhaustive. Always check with your doctor or pharmacist before combining Vitamin E (Tocopherol) with any medicine.

Caution
Warfarin & antiplatelet drugs
High-dose vitamin E can increase bleeding and raise INR with warfarin or antiplatelets.
Vitamin E inhibits platelet aggregation and antagonizes vitamin K-dependent clotting factors. NIH ODS — Vitamin E
Caution
Chemotherapy / radiation
High-dose vitamin E may theoretically interfere with oxidative chemo/radiation — discuss with oncologist.
Antioxidant activity may scavenge ROS used by some cytotoxic therapies. Antioxidants & supplements in cancer treatment (review)

Key Studies ★ 20 studies

systematic review Xiong 2023 (umbrella review) ✓ Full text
Umbrella review of 32 meta-analyses (64 health outcomes): higher vitamin E intake/circulating tocopherol was inversely associated with several cancers and Alzheimer's, but supplementation showed no benefit for cardiovascular mortality.
Meta-analysis Vitamin E MASH meta-analysis 2025 (Cureus) ✓ Full text
Systematic review/meta-analysis of 3 RCTs found vitamin E significantly reduced ALT (MD -12.27, 95% CI -16.66 to -7.89) and increased odds of fibrosis improvement (OR 1.96, 95% CI 1.25-3.09, no heterogeneity).
Meta-analysis Tocopherol periodontal meta-analysis 2024 (PMC) ✓ Full text
Systematic review and meta-analysis assessing tocopherol supplementation on clinical periodontal disease parameters in human trials.
Meta-analysis Maggio 2024 ✓ PubMed
Meta-analysis of 16 RCTs (doses 33-800 IU): vitamin E alone did not reduce ischemic or hemorrhagic stroke. Combined with other antioxidants it modestly reduced ischemic stroke (RR 0.91, 95% CI 0.84-0.99) but increased hemorrhagic stroke (RR 1.22, 95% CI 1.0-1.48), nullifying net benefit; not recommended for stroke prevention.
Meta-analysis Tripathi 2024 ✓ PubMed
Network meta-analysis of 56 studies (17 RCTs, 39 cohorts) on vitamins and stroke prevention found no significant association between vitamin E and reduced stroke risk (ranked near placebo, p-score 0.28), in contrast to vitamins C and D.
meta-analysis Vadarlis 2021 (meta-analysis) ✓ PubMed
Meta-analysis of RCTs in adults with NAFLD: vitamin E significantly reduced serum ALT and AST versus placebo and improved histologic steatosis/inflammation, especially in NASH.
meta-analysis Zhao 2022 (meta-analysis) ✓ PubMed
Meta-analysis (13 cohorts, ~46,968 participants): highest vs lowest vitamin E intake was associated with ~21% lower dementia risk (OR 0.79, 95% CI 0.70-0.88) and ~22% lower Alzheimer's risk (OR 0.78, 0.64-0.94).
Meta-analysis Keith 2021 (PLOS One) ✓ Full text
Systematic review/meta-analysis (20 studies) found lower serum vitamin E in patients with vitiligo (SMD -0.70), psoriasis (SMD -2.73), atopic dermatitis (SMD -1.08), and acne (SMD -0.67) versus controls.
Cochrane review Soares-Weiser 2018 (Cochrane review) ✓ PubMed
Cochrane review of 13 RCTs found no clear benefit of vitamin E over placebo for clinically important improvement of antipsychotic-induced tardive dyskinesia; evidence weak and inconclusive.
guideline EFSA NDA Panel 2024 (guideline) ✓ PubMed
EFSA retained a tolerable upper intake level of 300 mg/day alpha-tocopherol for adults, citing impaired blood clotting and bleeding risk as the critical adverse effect.
meta-analysis Schurks 2010 (meta-analysis) ✓ PubMed
Meta-analysis of 9 RCTs (118,765 participants): vitamin E increased hemorrhagic stroke risk by ~22% (RR 1.22) while reducing ischemic stroke ~10% (RR 0.90), with no effect on total stroke.
guideline USPSTF (Mangione) 2022 (guideline) ✓ PubMed
US Preventive Services Task Force recommends AGAINST vitamin E supplements for primary prevention of cardiovascular disease or cancer, finding no net benefit after reviewing 52 new studies.
Meta-analysis Miller 2005 (meta-analysis) ✓ PubMed
Meta-analysis of 19 trials (135,967 participants): high-dose vitamin E (≥400 IU/day) was associated with increased all-cause mortality.
RCT Wang 2025 (Cell Reports Medicine) ✓ Full text
Multi-center double-blind RCT in 124 non-diabetic biopsy-proven MASH patients: vitamin E 300 mg/day met the primary histologic endpoint in 29.3% vs 14.1% on placebo, with significant improvement in steatosis, lobular inflammation, and fibrosis stage.
RCT Klein 2011 SELECT (RCT) ✓ PubMed
In the SELECT trial (35,533 healthy men), vitamin E 400 IU/day significantly increased prostate cancer risk versus placebo (HR 1.17; absolute increase ~1.6 per 1,000 person-years).
RCT Chew 2013 AREDS2 (RCT) ✓ PubMed
AREDS2 RCT (4,203 participants at risk of late AMD): adding lutein+zeaxanthin and/or omega-3 to the AREDS formula (which contains 400 IU vitamin E) did not further reduce progression to advanced AMD.
RCT Sanyal (PIVENS) 2010 ✓ PubMed
In 247 non-diabetic adults with biopsy-proven NASH, vitamin E 800 IU/day for 96 weeks improved NASH histology in 43% vs 19% on placebo (P=0.001), with reductions in steatosis, lobular inflammation, and serum ALT/AST; no improvement in fibrosis. Landmark trial establishing vitamin E as first-line pharmacotherapy for non-diabetic NASH.
RCT Dysken (TEAM-AD) 2014 ✓ PubMed
In 613 patients with mild-to-moderate Alzheimer disease, alpha-tocopherol 2000 IU/day slowed functional decline on the ADCS-ADL inventory by ~19% vs placebo over a mean 2.3 years (a delay of ~6.2 months), without cognitive benefit and without increased mortality.
RCT Baumann & Spencer 1999 (RCT) ✓ PubMed
Double-blind split-scar RCT in 15 patients: topical vitamin E gave no cosmetic benefit (worse or unchanged in 90%) and caused contact dermatitis in 33%.
Preclinical Lin 2003 (experimental) ✓ PubMed
Topical 15% vitamin C + 1% alpha-tocopherol on skin gave ~4-fold antioxidant protection against UV erythema and DNA damage, beating either alone.
20 sources cited · 20 verified Search all studies on PubMed ↗

Common questions about Vitamin E (Tocopherol)

What is Vitamin E (Tocopherol) used for?

Vitamin E (Tocopherol) is most often taken for Lipid-soluble antioxidant in skin, May aid topical photoprotection with vitamin C, Possible barrier-lipid support (thin proof), Popular for scars — but not supported. Real antioxidant, but the scar-fading reputation is largely a myth

Does Vitamin E (Tocopherol) work — what does the evidence say?

Mixed evidence. Conflicting results across studies; benefit uncertain. Vitamin E (alpha-tocopherol) is a genuine lipid-soluble antioxidant that neutralizes reactive oxygen species in skin lipids — the basis of most cosmetic claims. However, its most popular use, topical vitamin E for scars or wound healing, is not supported: the landmark Baumann 1999 RCT found no cosmetic benefit and caused contact dermatitis in about a third of patients. Oral supplementation for skin appearance has weak, indirect evidence. The strongest signal is photoprotection when topical vitamin E is combined with vitamin C, though much of that work is in animal or small models. High-dose oral vitamin E carries its own risks, including bleeding and an association with higher all-cause mortality at ≥400 IU/day.

What is the typical dose of Vitamin E (Tocopherol)?

RDA ~15 mg/day (22.4 IU); doses ≥400 IU/day raise safety concerns.

Is Vitamin E (Tocopherol) safe? Any cautions or side effects?

Topical vitamin E commonly causes contact dermatitis (~1 in 3 in the Baumann scar trial). Oral vitamin E is safe at RDA levels (~15 mg/day), but high doses can increase bleeding risk (especially with anticoagulants or before surgery) and interfere with vitamin K; a 2005 meta-analysis linked ≥400 IU/day to higher all-cause mortality, so routine high-dose use for skin is not advisable.

How many studies support Vitamin E (Tocopherol)?

NutriDex cites 20 sources for Vitamin E (Tocopherol), graded "Mixed".

Does Vitamin E (Tocopherol) interact with any medications?

Yes — known or theoretical interactions include: Blood thinners (warfarin, DOACs) (caution), Chemotherapy / radiation (caution). This is educational and not exhaustive; always check with your doctor or pharmacist before combining Vitamin E (Tocopherol) with any medicine.

Cite this page
APA

Peh, D. (2026). Vitamin E (Tocopherol) (Alpha-tocopherol): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/vitamin-e

BibTeX
@misc{nutridex_vitamin_e,
  author       = {Peh, Daryl},
  title        = {Vitamin E (Tocopherol) (Alpha-tocopherol): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/vitamin-e},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances